Today marks a historic milestone in Genetrump's journey toward industrialization! Under the promotion of the Institute of Translational Medicine at the University of Macau, we have officially signed a tripartite cooperation agreement in Zhongshan with the Chen Xinghai Hospital of Integrated Traditional Chinese and Western Medicine and Guangdong-Macao Pharmaceutical Co., Ltd. This launches a landmark Guangdong-Macao project for TCM development, integrating medicine, industry, academia, and research.
This powerful alliance brings together the strengths of a university, a hospital, and an enterprise. It leverages the specialized platform of the "Guangdong-Macao Medical Institution TCM Preparation Center" operated by Guangdong-Macao Pharmaceutical in Hengqin, combining our foundational innovative technology from the University of Macau with the premier clinical resources of Chen Xinghai Hospital. Our shared goal is to develop novel TCM preparations and activate "new quality productive forces" within the TCM industry.
The first core initiative under this collaboration will be our flagship product: the "Eucommia Polysaccharide Wound Dressing." This innovative dressing, originating from the University of Macau's independent research and being industrialized by Genetrump, will now officially advance toward clinical application and pharmaceutical preparation, offering a new solution for patients with chronic wounds like diabetic foot ulcers.
Chen Xinghai Hospital, as a top-tier hospital and a pioneer of the "Hong Kong and Macao Medicine and Medical Device Pass" policy, possesses significant clinical demand and robust translational capabilities. This partnership is not just a critical step for our core technology's clinical journey; it is a vivid example of the deep integration between Guangdong and Macau to build a leading-edge incubation platform for TCM innovation.
Genetrump will seize this opportunity to work closely with our partners, fully committed to translating Macau's cutting-edge medical research into tangible clinical benefits and widespread application across the Greater Bay Area, truly realizing our mission to serve public health with "China's Smart Manufacturing."
Source: Genetrump News
